Udayavni Special

Top Chinese official admits country’s vaccines have low effectiveness


PTI, Apr 12, 2021, 12:11 PM IST

Beijing: In a rare admission of the weakness of Chinese anti-COVID-19 vaccines, the country’s top disease control official says their effectiveness is low and the government is considering mixing them to get a boost.

Chinese vaccines ”don’t have very high protection rates,” said the director of the China Centres for Disease Control, Gao Fu, at a conference Saturday in the southwestern city of Chengdu.

Beijing has distributed hundreds of millions of doses abroad while trying to promote doubt about the effectiveness of the Pfizer-BioNTech vaccine made using the previously experimental messenger RNA, or mRNA, process.

”It’s now under formal consideration whether we should use different vaccines from different technical lines for the immunization process,” Gao said.

Officials at a news conference Sunday didn’t respond directly to questions about Gao’s comment or possible changes in official plans. But another CDC official said developers are working on mRNA-based vaccines.

Gao did not respond to a phone call requesting further comment.

”The mRNA vaccines developed in our country have also entered the clinical trial stage,” said the official, Wang Huaqing. He gave no timeline for possible use.

Experts say mixing vaccines, or sequential immunization, might boost effectiveness.

Researchers in Britain are studying a possible combination of Pfizer-BioNTech and the traditional AstraZeneca vaccine.

The COVID-19 pandemic, which began in central China in late 2019, marks the first time the Chinese drug industry has played a role in responding to a global health emergency.

Vaccines made by Sinovac, a private company, and Sinopharm, a government-owned firm, have made up the majority of Chinese vaccines distributed to several dozen countries including Mexico, Turkey, Indonesia, Hungary and Brazil.

The effectiveness of a Sinovac vaccine at preventing symptomatic infections was found to be as low as 50.4 per cent by researchers in Brazil, near the 50% threshold at which health experts say a vaccine is useful.

By comparison, the Pfizer-BioNTech vaccine has been found to be 97 per cent effective.

Health experts say Chinese vaccines are unlikely to be sold to the United States, western Europe and Japan due to the complexity of the approval process.

A Sinovac spokesman, Liu Peicheng, acknowledged varying levels of effectiveness have been found but said that can be due to the age of people in a study, the strain of virus and other factors.

Beijing has yet to approve any foreign vaccines for use in China.

Gao gave no details of possible changes in strategy but cited mRNA as a possibility.

”Everyone should consider the benefits mRNA vaccines can bring for humanity,” Gao said. ”We must follow it carefully and not ignore it just because we already have several types of vaccines already.”

Gao previously questioned the safety of mRNA vaccines. He was quoted by the official Xinhua News Agency as saying in December he couldn’t rule out negative side effects because they were being used for the first time on healthy people.

Chinese state media and popular health and science blogs also have questioned the safety and effectiveness of the Pfizer-BioNTech vaccine.

As of April 2, some 34 million people in China have received both of the two doses required for Chinese vaccines and about 65 million received one, according to Gao.

The Sinovac spokesman, Liu, said studies find protection ”may be better” if time between vaccinations is longer than the current 14 days but gave no indication that might be made standard practice.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Siddu says oxygen produced in state should be reserved for our K’taka

Shocked by Centre moving SC against HC order to hike oxygen supply to K’taka: Cong

Congress demands arrest of Tejasvi Surya, BJP MLA Sathish Reddy for bed scam

Mamata announces compensation of Rs 2 lakh each for families of post-poll violence victims

Covid-19 lockdown: Stringent curbs in Dakshina Kannada from tom

Centre moves SC against Karnataka HC order asking enhancement of LMO for state

PM reviews COVID-19 situation, stresses states should not let vaccination speed go down


Related Articles More

US reverses stance, backs Covid vaccine patent waiver

Pak court asks India to cooperate in Jadhav case

Woman from Mali gives birth to 9 babies in Morocco

Tragic COVID-19 situation in India should raise alarm bells for all of us: UNICEF

Indian-origin immunologist Sankar Ghosh elected to National Academy of Sciences

MUST WATCH

Udayavani 6 -May -2021 News Bulletin

West Bengal: Union Minister V Muraleedharan’s car attacked by locals

Megha Shetty Awareness Message | Stay Home Stay Safe

NREGA wage discrimination: Assault on computer operator

Protest in front of CM’s house

Latest Additions

Siddu says oxygen produced in state should be reserved for our K’taka

Shocked by Centre moving SC against HC order to hike oxygen supply to K’taka: Cong

Congress demands arrest of Tejasvi Surya, BJP MLA Sathish Reddy for bed scam

Mamata announces compensation of Rs 2 lakh each for families of post-poll violence victims

Covid-19 lockdown: Stringent curbs in Dakshina Kannada from tom

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.